+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 4ay5 | ||||||
---|---|---|---|---|---|---|---|
タイトル | Human O-GlcNAc transferase (OGT) in complex with UDP and glycopeptide | ||||||
要素 |
| ||||||
キーワード | TRANSFERASE/PEPTIDE / TRANSFERASE-PEPTIDE COMPLEX / TRANSFERASE / GLYCOSYL TRANSFERASE / TRIMERIC PRODUCT COMPLEX / O-GLCNAC | ||||||
機能・相同性 | 機能・相同性情報 negative regulation of non-canonical inflammasome complex assembly / protein N-acetylglucosaminyltransferase complex / regulation of insulin receptor signaling pathway / protein O-acetylglucosaminyltransferase activity / protein O-GlcNAc transferase / positive regulation of cGAS/STING signaling pathway / positive regulation of transcription from RNA polymerase II promoter by glucose / cardiac septum development / acetylglucosaminyltransferase activity / regulation of Rac protein signal transduction ...negative regulation of non-canonical inflammasome complex assembly / protein N-acetylglucosaminyltransferase complex / regulation of insulin receptor signaling pathway / protein O-acetylglucosaminyltransferase activity / protein O-GlcNAc transferase / positive regulation of cGAS/STING signaling pathway / positive regulation of transcription from RNA polymerase II promoter by glucose / cardiac septum development / acetylglucosaminyltransferase activity / regulation of Rac protein signal transduction / regulation of necroptotic process / negative regulation of stem cell population maintenance / coronary vasculature development / protein O-linked glycosylation / NSL complex / aorta development / regulation of glycolytic process / non-canonical NF-kappaB signal transduction / regulation of neurotransmitter receptor localization to postsynaptic specialization membrane / RIPK1-mediated regulated necrosis / regulation of synapse assembly / regulation of gluconeogenesis / protein serine/threonine phosphatase activity / mitogen-activated protein kinase p38 binding / positive regulation of stem cell population maintenance / Formation of WDR5-containing histone-modifying complexes / Sin3-type complex / positive regulation of proteolysis / phosphatidylinositol-3,4,5-trisphosphate binding / hemopoiesis / histone acetyltransferase complex / mitophagy / heart morphogenesis / positive regulation of lipid biosynthetic process / negative regulation of proteasomal ubiquitin-dependent protein catabolic process / negative regulation of protein ubiquitination / IRAK2 mediated activation of TAK1 complex / Alpha-protein kinase 1 signaling pathway / IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation / TICAM1,TRAF6-dependent induction of TAK1 complex / positive regulation of TORC1 signaling / TRAF6-mediated induction of TAK1 complex within TLR4 complex / protein serine/threonine kinase activator activity / transforming growth factor beta receptor signaling pathway / response to nutrient / JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 / negative regulation of cell migration / TNFR1-induced NF-kappa-B signaling pathway / cell projection / positive regulation of translation / activated TAK1 mediates p38 MAPK activation / cellular response to glucose stimulus / lung development / mitochondrial membrane / negative regulation of transforming growth factor beta receptor signaling pathway / circadian regulation of gene expression / NOD1/2 Signaling Pathway / response to insulin / TAK1-dependent IKK and NF-kappa-B activation / positive regulation of protein serine/threonine kinase activity / Regulation of necroptotic cell death / chromatin DNA binding / CLEC7A (Dectin-1) signaling / protein processing / FCERI mediated NF-kB activation / Interleukin-1 signaling / UCH proteinases / positive regulation of cold-induced thermogenesis / chromatin organization / HATs acetylate histones / in utero embryonic development / positive regulation of MAPK cascade / molecular adaptor activity / endosome membrane / Ub-specific processing proteases / nuclear speck / glutamatergic synapse / endoplasmic reticulum membrane / protein-containing complex binding / regulation of transcription by RNA polymerase II / apoptotic process / SARS-CoV-2 activates/modulates innate and adaptive immune responses / positive regulation of DNA-templated transcription / negative regulation of transcription by RNA polymerase II / endoplasmic reticulum / signal transduction / positive regulation of transcription by RNA polymerase II / protein-containing complex / nucleoplasm / nucleus / plasma membrane / cytosol / cytoplasm 類似検索 - 分子機能 | ||||||
生物種 | HOMO SAPIENS (ヒト) SYNTHETIC CONSTRUCT (人工物) | ||||||
手法 | X線回折 / シンクロトロン / OTHER / 解像度: 3.15 Å | ||||||
データ登録者 | Schimpl, M. / Zheng, X. / Blair, D.E. / Schuettelkopf, A.W. / Navratilova, I. / Aristotelous, T. / Ferenbach, A.T. / Macnaughtan, M.A. / Borodkin, V.S. / van Aalten, D.M.F. | ||||||
引用 | ジャーナル: Nat.Chem.Biol. / 年: 2012 タイトル: O-Glcnac Transferase Invokes Nucleotide Sugar Pyrophosphate Participation in Catalysis 著者: Schimpl, M. / Zheng, X. / Borodkin, V.S. / Blair, D.E. / Ferenbach, A.T. / Schuettelkopf, A.W. / Navratilova, I. / Aristotelous, T. / Albarbarawi, O. / Robinson, D.A. / Macnaughtan, M.A. / Van Aalten, D.M.F. | ||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 4ay5.cif.gz | 548.5 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb4ay5.ent.gz | 454.3 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 4ay5.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 4ay5_validation.pdf.gz | 1.6 MB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 4ay5_full_validation.pdf.gz | 1.7 MB | 表示 | |
XML形式データ | 4ay5_validation.xml.gz | 102.5 KB | 表示 | |
CIF形式データ | 4ay5_validation.cif.gz | 137.9 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/ay/4ay5 ftp://data.pdbj.org/pub/pdb/validation_reports/ay/4ay5 | HTTPS FTP |
-関連構造データ
-リンク
-集合体
登録構造単位 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
単位格子 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
非結晶学的対称性 (NCS) | NCSドメイン:
NCSドメイン領域:
NCS oper:
|
-要素
#1: タンパク質 | 分子量: 80974.508 Da / 分子数: 4 断片: TPR (TRUNCATED) AND CATALYTIC DOMAIN, RESIDUES 313-1031 由来タイプ: 組換発現 / 由来: (組換発現) HOMO SAPIENS (ヒト) / プラスミド: PGEX6P1 / 発現宿主: ESCHERICHIA COLI (大腸菌) / 株 (発現宿主): BL21 / Variant (発現宿主): ARCTICEXPRESS (RIL) / 参照: UniProt: O15294, protein O-GlcNAc transferase #2: タンパク質・ペプチド | 分子量: 1121.198 Da / 分子数: 4 / 由来タイプ: 合成 / 由来: (合成) SYNTHETIC CONSTRUCT (人工物) / 参照: UniProt: Q15750*PLUS #3: 化合物 | ChemComp-UDP / #4: 糖 | ChemComp-NAG / 配列の詳細 | CHAINS I, J, K, AND L ARE GTAB1TIDE, A SYNTHETIC GLYCOPEPTIDE BASED ON RESIDUES 389-399 OF HUMAN ...CHAINS I, J, K, AND L ARE GTAB1TIDE, A SYNTHETIC GLYCOPEPTI | |
---|
-実験情報
-実験
実験 | 手法: X線回折 / 使用した結晶の数: 1 |
---|
-試料調製
結晶 | マシュー密度: 4.7 Å3/Da / 溶媒含有率: 73.81 % / 解説: NONE |
---|---|
結晶化 | pH: 9.3 / 詳細: 1.45 M K2HPO4, 10 MM EDTA, 1% XYLITOL, pH 9.3 |
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: シンクロトロン / サイト: ESRF / ビームライン: ID14-4 / 波長: 0.939 |
検出器 | タイプ: ADSC QUANTUM 315r / 検出器: CCD / 日付: 2011年5月1日 |
放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 0.939 Å / 相対比: 1 |
反射 | 解像度: 3.15→30 Å / Num. obs: 105108 / % possible obs: 99.7 % / Observed criterion σ(I): 2 / 冗長度: 3.6 % / Rmerge(I) obs: 0.11 / Net I/σ(I): 6.7 |
-解析
ソフトウェア | 名称: REFMAC / バージョン: 5.6.0117 / 分類: 精密化 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: OTHER 開始モデル: NONE 解像度: 3.15→237.44 Å / Cor.coef. Fo:Fc: 0.947 / Cor.coef. Fo:Fc free: 0.925 / SU B: 13.759 / SU ML: 0.223 / 交差検証法: THROUGHOUT / ESU R: 0.673 / ESU R Free: 0.298 / 立体化学のターゲット値: MAXIMUM LIKELIHOOD 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. RESIDUES 715-718 AND 747-761 ARE DISORDERED.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å / 溶媒モデル: MASK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 60.844 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 3.15→237.44 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
|